Christopher Schriever

797 total citations
17 papers, 565 citations indexed

About

Christopher Schriever is a scholar working on Infectious Diseases, Clinical Biochemistry and Virology. According to data from OpenAlex, Christopher Schriever has authored 17 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 5 papers in Clinical Biochemistry and 3 papers in Virology. Recurrent topics in Christopher Schriever's work include Bacterial Identification and Susceptibility Testing (5 papers), HIV/AIDS drug development and treatment (4 papers) and HIV Research and Treatment (3 papers). Christopher Schriever is often cited by papers focused on Bacterial Identification and Susceptibility Testing (5 papers), HIV/AIDS drug development and treatment (4 papers) and HIV Research and Treatment (3 papers). Christopher Schriever collaborates with scholars based in United States, Belgium and Poland. Christopher Schriever's co-authors include Stuart Johnson, Dale N. Gerding, Minerva Galang, Ciarán P. Kelly, Keith A. Rodvold, Larry H. Danziger, Toral Patel, David W. Hecht, Ursula Patel and Israel Rubinstein and has published in prestigious journals such as Clinical Infectious Diseases, American Journal of Public Health and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Christopher Schriever

16 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Schriever United States 9 429 325 80 60 42 17 565
N Shinagawa Japan 7 443 1.0× 221 0.7× 93 1.2× 58 1.0× 86 2.0× 31 612
Christer Lidman Sweden 16 248 0.6× 510 1.6× 28 0.3× 45 0.8× 41 1.0× 32 657
Florian Daxböck Austria 11 175 0.4× 183 0.6× 80 1.0× 88 1.5× 56 1.3× 14 475
María Olmedo Spain 11 313 0.7× 204 0.6× 60 0.8× 38 0.6× 60 1.4× 30 412
Megan Shaughnessy United States 8 455 1.1× 200 0.6× 82 1.0× 84 1.4× 119 2.8× 16 579
Francesca Crea Italy 13 220 0.5× 213 0.7× 97 1.2× 29 0.5× 88 2.1× 21 612
Faisal Alasmari Saudi Arabia 9 246 0.6× 208 0.6× 117 1.5× 47 0.8× 26 0.6× 24 407
Diana L. Pakstis United States 14 360 0.8× 476 1.5× 268 3.4× 79 1.3× 38 0.9× 19 994
Minerva Galang United States 3 533 1.2× 418 1.3× 128 1.6× 39 0.7× 27 0.6× 3 591
Michael Somero United States 6 679 1.6× 566 1.7× 229 2.9× 19 0.3× 67 1.6× 7 896

Countries citing papers authored by Christopher Schriever

Since Specialization
Citations

This map shows the geographic impact of Christopher Schriever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Schriever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Schriever more than expected).

Fields of papers citing papers by Christopher Schriever

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Schriever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Schriever. The network helps show where Christopher Schriever may publish in the future.

Co-authorship network of co-authors of Christopher Schriever

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Schriever. A scholar is included among the top collaborators of Christopher Schriever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Schriever. Christopher Schriever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chapman, Heather, et al.. (2020). Potential Perinatally Acquired Extended Spectrum β-Lactamase Escherichia coli Urinary Tract Infection in an Infant. The Journal of Pediatric Pharmacology and Therapeutics. 25(3). 266–269.
2.
Schriever, Christopher, et al.. (2019). Comparing drug interaction frequencies of various hepatitis C treatment regimens among monoinfected patients. Annals of Hepatology. 18(4). 601–606. 2 indexed citations
3.
Michienzi, Sarah M., Sean Kim, Nimish Patel, et al.. (2019). 356. HIV-HCV Coinfection: An Investigation of CD4 T-Cell Reconstitution after HCV Direct-Acting Antiviral Treatment. Open Forum Infectious Diseases. 6(Supplement_2). S187–S187. 2 indexed citations
4.
Schriever, Christopher, et al.. (2018). Treatment considerations for potential uropathogens detected by precision microbiological testing. American Journal of Health-System Pharmacy. 75(22). 1775–1782. 5 indexed citations
5.
Michienzi, Sarah M., Christopher Schriever, & Melissa E. Badowski. (2018). Abacavir/lamivudine/dolutegravir single tablet regimen in patients with human immunodeficiency virus and end-stage renal disease on hemodialysis. International Journal of STD & AIDS. 30(2). 181–187. 17 indexed citations
6.
Badowski, Melissa E., et al.. (2018). Sustained viral suppression with co-administration of oxcarbazepine and dolutegravir. International Journal of STD & AIDS. 29(8). 831–833. 5 indexed citations
7.
Schriever, Christopher, et al.. (2018). Fostering Interprofessional Education Through a Multidisciplinary, Community-Based Pandemic Mass Vaccination Exercise. American Journal of Public Health. 108(3). 358–360. 8 indexed citations
8.
Johnson, Stuart, Christopher Schriever, Ursula Patel, et al.. (2009). Rifaximin Redux: Treatment of recurrent Clostridium difficile infections with Rifaximin immediately post-vancomycin treatment. Anaerobe. 15(6). 290–291. 104 indexed citations
9.
Johnson, Stuart, Christopher Schriever, Minerva Galang, Ciarán P. Kelly, & Dale N. Gerding. (2007). Interruption of Recurrent Clostridium difficile-Associated Diarrhea Episodes by Serial Therapy with Vancomycin and Rifaximin. Clinical Infectious Diseases. 44(6). 846–848. 242 indexed citations
10.
Jain, Rupali, Christopher Schriever, Larry H. Danziger, Sang‐Hyun Cho, & Israel Rubinstein. (2007). The IS<i>6110</i> Repetitive DNA Element of <i>Mycobacterium tuberculosis</i> Is Not Detected in Exhaled Breath Condensate of Patients with Active Pulmonary Tuberculosis. Respiration. 74(3). 329–333. 17 indexed citations
11.
Schriever, Christopher, Cristina Fernández, Keith A. Rodvold, & Larry H. Danziger. (2005). Daptomycin: A novel cyclic lipopeptide antimicrobial. American Journal of Health-System Pharmacy. 62(11). 1145–1158. 61 indexed citations
12.
Pai, Manjunath P., et al.. (2004). Sex‐Related Differences in the Pharmacokinetics of Once‐Daily Saquinavir Soft‐Gelatin Capsules Boosted with Low‐Dose Ritonavir in Patients Infected with Human Immunodeficiency Virus Type 1. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(5). 592–599. 28 indexed citations
13.
Schriever, Christopher, Susan L. Pendland, John P. Quinn, et al.. (2004). Pharmacokinetics and Pharmacodynamics of Intravenous Levofloxacin at 750 Milligrams and Various Doses of Metronidazole in Healthy Adult Subjects. Antimicrobial Agents and Chemotherapy. 48(12). 4597–4605. 24 indexed citations
14.
Rubinstein, Israel, Brijesh Kumar, & Christopher Schriever. (2003). Long-term montelukast therapy in moderate to severe COPD—a preliminary observation. Respiratory Medicine. 98(2). 134–138. 37 indexed citations
15.
Pendland, Susan L., et al.. (2002). In vitro bactericidal activity of piperacillin, gentamicin, and metronidazole in a mixed model containing Escherichia coli, Enterococcus faecalis, and Bacteroides fragilis. Diagnostic Microbiology and Infectious Disease. 43(2). 149–156. 6 indexed citations
16.
Jung, Rose, Chad R. Messick, Susan L. Pendland, et al.. (2000). Postantibiotic Effects and Bactericidal Activities of Clarithromycin–14-Hydroxy-Clarithromycin, versus Those of Amoxicillin-Clavulanate, against Anaerobes. Antimicrobial Agents and Chemotherapy. 44(3). 778–779. 1 indexed citations
17.
Gapany, M., et al.. (1990). Tumor Necrosis Factor and Cytotoxic Agents: Effect on Squamous Carcinoma Lines. Archives of Otolaryngology - Head and Neck Surgery. 116(4). 436–439. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N Shinagawa Breakdown of academic impact, for papers by Christer Lidman Breakdown of academic impact, for papers by Florian Daxböck Breakdown of academic impact, for papers by María Olmedo Breakdown of academic impact, for papers by Megan Shaughnessy Breakdown of academic impact, for papers by Francesca Crea Breakdown of academic impact, for papers by Faisal Alasmari Breakdown of academic impact, for papers by Diana L. Pakstis Breakdown of academic impact, for papers by Minerva Galang Breakdown of academic impact, for papers by Michael Somero
Rankless by CCL
2026